Oral Ceramides: The Inside-Out Approach to Skin Barrier Repair
Ceramides make up approximately 50% of the lipid matrix in the skin’s stratum corneum. They’re what keep water in and irritants out. As skin ages, or in conditions like atopic dermatitis, ceramide content drops and barrier function deteriorates. While topical ceramide products have been standard skincare for years, the case for oral ceramide supplementation is quietly accumulating clinical weight.
Three Sources, Consistent Results
The published trials have used ceramides from three primary botanical and animal sources.
Rice ceramides (open-label clinical study): After four weeks of supplementation, participants showed a 15.31% reduction in fine lines, a 17.90% decrease in wrinkles, a 16.90% increase in skin moisture content, and a 2.06% improvement in skin brightness. Over 90% of participants reported subjective improvement in texture and softness. No adverse effects were observed.
Wine lees extract ceramides (double-blind, placebo-controlled RCT, MDPI Nutrients 2024): After 12 weeks, the treatment group showed statistically significant reduction in transepidermal water loss (TEWL) compared to placebo (p = 0.04). TEWL is the gold-standard objective measure of barrier integrity—lower is better. The combination of ceramides and glucosylceramides in this formulation was proposed as particularly effective for barrier function.
Milk ceramides (double-blind, placebo-controlled RCT, 12 weeks): Improvements in eye-area hydration, skin elasticity, and reduction of fine lines around the eyes were all confirmed compared to placebo.
How Oral Ceramides Reach the Skin
Two pathways are proposed. In the first, absorbed ceramides and their metabolites enter circulation and become substrates for ceramide biosynthesis in the epidermis, replenishing the lipid matrix from within. In the second, glucosylceramides specifically strengthen the intestinal epithelial barrier, reducing systemic inflammation that can manifest as skin reactivity and dryness.
Glucosylceramides have a bioavailability advantage over standard ceramides: their glycosylated form survives the digestive process better and is absorbed more efficiently. This is why most clinical formulations now emphasize plant-derived glucosylceramides or combinations.
Topical vs. Oral: Not Either/Or
The current evidence points toward combination use as the most effective strategy. Topical ceramides act immediately at the surface, sealing transepidermal water loss and blocking irritant entry. Oral ceramides work at the metabolic level over weeks, increasing the substrate available for epidermal lipid production.
The two approaches target different layers of the same system. For persistently dry or reactive skin, or when topical-only routines stop delivering results across seasons, oral ceramides represent a well-tolerated adjunct. Clinical doses across the reviewed trials generally range from 30 to 200mg per day, depending on source and formulation.
Sources
Nutrients (MDPI) - Efficacy and Safety of Oral Administration of Wine Lees Extract-Derived Ceramides